Volume 13, Issue 9b pp. 3753-3763

Cyclooxygenase in normal human tissues – is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?

Nina Zidar

Corresponding Author

Nina Zidar

Institute of Pathology, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia

Correspondence to: Nina ZIDAR, Institute of Pathology, Medical Faculty, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia.
Tel.: +386-1-543-71 49
Fax: +386-1-543-7101
E-mail: [email protected]Search for more papers by this author
Katarina Odar

Katarina Odar

Institute of Pathology, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia

Search for more papers by this author
Damjan Glavac

Damjan Glavac

Institute of Pathology, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia

Search for more papers by this author
Maja Jerse

Maja Jerse

Institute of Pathology, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia

Search for more papers by this author
Tomaz Zupanc

Tomaz Zupanc

Institute of Forensic Medicine, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia

Search for more papers by this author
Dusan Stajer

Dusan Stajer

Centre for Intensive Internal Medicine, University Medical Centre, Ljubljana, Slovenia

Search for more papers by this author
First published: 29 January 2010
Citations: 201

Abstract

Cyclooxygenase (COX) is a key enzyme in prostanoid synthesis. It exists in two isoforms, COX-1 and COX-2. COX-1 is referred to as a ‘constitutive isoform’, and is considered to be expressed in most tissues under basal conditions. In contrast, COX-2 is referred to as an ‘inducible isoform’, which is believed to be undetectable in most normal tissues, but can be up-regulated during various conditions, many of them pathological. Even though the role of COX in homeostasis and disease in now well appreciated, controversial information is available concerning the distribution of COX isoforms in normal human tissues. There is mounting evidence that it is much more complex than generally believed. Our aim was therefore to analyse the expression and distribution of COX isoforms in normal human tissues, using immunohistochemistry, Western blotting and real-time RT-PCR. Autopsy samples from 20 healthy trauma victims and samples from 48 biopsy surgical specimens were included. COX-1 was found in blood vessels, interstitial cells, smooth muscle cells, platelets and mesothelial cells. In contrast, COX-2 was found predominantly in the parenchymal cells of many tissues, with few exceptions, for example the heart. Our results confirm the hypothesis that the distribution of COX isoforms in healthy tissues is much more complex than generally believed. This and previous studies indicate that both isoforms, not only COX-1, are present in many normal human tissues, and that both isoforms, not only COX-2, are up-regulated in various pathological conditions. We may have to revise the concept of ‘constitutive’ and ‘inducible’ COX isoforms.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.